- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sodium-Glucose Transporter 2 Inhibitors in Colombia
Total 420 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, United Kingdom, Canada, Austria, Serbia, Germany, South Africa, Malaysia, Czechia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyFrance, Poland, United States, Belgium, Germany, Spain, India, Romania, South Africa, Canada, Australia, Korea, Republic of, New Zealand, Russian Federation, Brazil, Malaysia, Latvia, Mexico
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Spain, Taiwan, United Kingdom, Czechia, Bulgaria, Israel, Canada, Germany, Malaysia, Argentina, Hungary, Russian Federation, Poland, Ukraine, Korea, Republic of, Croatia, Japan, Netherlands, Portugal, South Africa, ... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Italy, United Kingdom, France, Serbia, Germany, South Africa, Canada, Ukraine, United Arab Emirates
-
TakedaTerminatedDiabetes Mellitus, Type 2United States, Ukraine, Poland, Malaysia, Canada, Peru, Philippines, Hungary, Russian Federation, South Africa, Argentina, Croatia, Thailand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Russian Federation, Slovakia, Spain, Canada, Taiwan, Finland, Hungary, Malaysia, South Africa, United Kingdom, Germany, Australia, Thailand, Ireland, Puerto Rico, Singapore
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Canada, France, Poland, Germany, Israel, India, Ukraine, Korea, Republic of, Malaysia, Netherlands, New Zealand, Singapore, Brazil, Austria, Denmark, Belgium
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Ukraine, Israel, Mexico, Romania, Russian Federation, South Africa, Czech Republic, Puerto Rico, Poland, Hungary, Lithuania, Slovakia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, United Kingdom, Korea, Republic of, Peru, South Africa, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Italy, Russian Federation, Spain, Canada, Serbia, Slovakia, Germany, Greece, Korea, Republic of, Czechia, Puerto Rico, Bulgaria, Romania, Argentina, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Israel, Russian Federation, Slovakia, Canada, Serbia, United Kingdom, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedHypertension | Cardiovascular Disease | Type 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Vietnam, Germany, Romania, Canada, Argentina, Slovakia, Taiwan, Spain
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2United States, Chile, Hong Kong, Argentina, Austria, Brazil, Canada, Mexico, Peru, Puerto Rico, Philippines, Thailand, Russian Federation, Poland, Germany, Taiwan, Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Puerto Rico, United Kingdom, Ireland, Germany, Slovenia, Canada, France, Italy, Spain, Netherlands, Slovakia, Romania, Former Serbia and Montenegro
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Israel, Italy, Mexico, Puerto Rico, Russian Federation, Spain, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Taiwan, Finland, Norway, Serbia, South Africa, Turkey, Canada, France, Germany, Korea, Republic of and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Russian Federation, United Kingdom, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Canada, Denmark, Hungary, Serbia, Germany, Greece, Romania, Estonia, Norway
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Mexico, Peru, Russian Federation, United Kingdom, Philippines, South Africa, Spain, Hong Kong, Albania
-
Eli Lilly and CompanyCompletedCardiovascular Disease | Diabetes Mellitus, Type 2Argentina, Canada, Germany, Spain, United Kingdom, United States, Hungary, Puerto Rico, Bulgaria, Poland, Korea, Republic of, Australia, Brazil, Mexico, Chile, Colombia, Czechia, Latvia, Lithuania, New Zealand, Romania, Russian Federation and more
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, Colombia, Hungary, India, Lithuania, Peru, Romania
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes Mellitus | Chronic Kidney Disease Stage 3United States, Argentina, Brazil, Canada, Colombia, Germany, Hungary, Israel, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2United States, Belgium, Bulgaria, Colombia, Czech Republic, Finland, France, Germany, Guatemala, Mexico, Peru, Russian Federation, Spain, Ukraine
-
BayerCompletedDiabetic NephropathiesHong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
-
PfizerSanofiCompleted
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
AstraZenecaCompletedChronic Kidney Diseases | Type 2 Diabetes MellitusSpain, United Kingdom, New Zealand, Australia, Canada, Poland, Germany, Japan
-
AstraZenecaCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Spain, India, Belgium, Argentina, Austria, France, Mexico
-
GlaxoSmithKlineCompleted
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | AlbuminuriaAustralia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, France, Spain, Sweden, China, Korea, Republic of, United States, Canada, Germany, Ireland, Mexico, Poland, India, Denmark, Hungary, United Kingdom, New Zealand, Malaysia, Netherlands, Russian Federation, Thailand, Romania, Ita... and more
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, France, Canada, Brazil, Russian Federation, Netherlands, Switzerland, Turkey, Malaysia, Taiwan, Czech Republic, Finland, Italy, Colombia, South Africa, Greece
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
The George InstituteServierCompletedDiabetes Mellitus, Type 2Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
-
NovartisCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencySpain, Canada, France, Germany, Australia, Costa Rica, Finland, Russian Federation, Argentina, India, Norway, Sweden
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary